Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology · Resistance to Thyroid Hormone

Living With RTH: Long-Term Monitoring and Advocacy

At a Glance

Living with resistance to thyroid hormone requires individualized, lifelong follow-up. Monitoring may include heart checks, cholesterol and liver tests, and growth or anemia assessments by subtype, while a clear medical summary helps coordinate care and avoid misreading usual lab results.

Living with Resistance to Thyroid Hormone (RTH) is a lifelong journey. Because the condition is rare and complex, your role as an informed advocate for your own health is vital. Long-term care focuses on protecting the organs that are sensitive to your hormone levels while ensuring your “resistant” tissues get the support they need [1][2].

Protecting Your Heart (Especially in RTH-Beta)

While your brain and liver may be “resistant” to thyroid hormone, your heart often remains sensitive. Your heart can be exposed to high levels of hormones [3].

Observational cohort studies of rare disease populations suggest that patients with RTH-Beta may have higher relative risks for several heart conditions compared to the general population [4]:

  • Atrial Fibrillation (Afib): An irregular and often rapid heart rate.
  • Heart Failure: The heart may eventually weaken.
  • Tachycardia: A resting heart rate that is consistently too fast [5].

While these studies report relative risks (e.g., 6 to 10 times higher risk), remember that your absolute, individual risk may be lower. Monitoring should be individualized based on your symptoms and clinical exam. Your doctor may recommend periodic EKGs (electrocardiograms), echocardiography, or a blood test called NT-proBNP when clinically indicated [1][6].

Metabolic and Liver Health

RTH-Beta may be associated with unusual metabolic patterns, and individualized metabolic assessment is recommended:

  • Mixed Dyslipidemia: This includes abnormal cholesterol levels [7][8].
  • Liver Fat (Hepatic Steatosis): Hepatic steatosis may be associated with RTH, as the liver’s receptors may not properly process fats [7][9].

Standard long-term monitoring generally includes lipid panels and liver enzyme tests [7]. Imaging like a FibroScan is risk- or finding-based rather than routine for every patient [9].

RTH-Alpha Specific Monitoring

If you or your child has RTH-Alpha, long-term monitoring has a different focus. Care often centers on tracking:

  • Growth and Development: Ensuring height and bone maturation stay on track.
  • Bowel Function: Managing chronic constipation.
  • Heart Rate: Checking for bradycardia (slow heart rate) or tachycardia if on L-T4 treatment.
  • Blood Health: Monitoring for anemia.

When Other Thyroid Issues Arise

Having RTH does not protect you from more common thyroid problems. It is possible to develop conditions like Hashimoto’s thyroiditis (an autoimmune underactive thyroid) or Graves’ disease (an autoimmune overactive thyroid) [10][11].

If you develop Hashimoto’s, your thyroid may no longer be able to produce the “compensatory” levels of hormone your body needs. In these cases, you may need Levothyroxine therapy to bring your hormones back up to the levels that are “normal” for you [2].

Advocacy and Navigating Care

Because RTH is so rare, you will often find yourself “teaching” your doctors.

Strategies for successful advocacy include:

  1. Keep a Master File: Always have copies of your genetic test results and a summary of your usual lab ranges [12].
  2. Use a Specialist: Ensure your primary care doctor coordinates with an endocrinologist [12].
  3. Medical Alert Card: Consider carrying a card that lists:
    • Your confirmed RTH subtype and genetic result (if known).
    • Your usual laboratory pattern.
    • Your current medications.
    • Your endocrinologist’s contact information.
    • A statement such as: “Do not change thyroid treatment solely based on abnormal lab results without specialist input.” (This is safer than a blanket instruction to avoid treatment, as you might need emergency care for a genuinely new problem).

Follow-up schedules are individualized; adults, children, and pregnant women all require different frequencies of care [13][2].

Common questions in this guide

How often do I need heart checks if I have RTH?
There is no single schedule for everyone with RTH. An endocrinologist may recommend an EKG, echocardiogram, or NT-proBNP blood test based on your RTH subtype, symptoms, examination, and other health factors. RTH-Beta and symptoms such as palpitations, a persistently fast pulse, or shortness of breath may prompt closer assessment.
Does RTH increase the risk of heart problems?
In RTH-Beta, the heart may remain sensitive to high thyroid hormone levels, and studies have found associations with rapid heartbeat, atrial fibrillation, and heart failure. This does not determine your individual outcome because absolute risk varies. Ask your clinician what heart rate or symptoms should prompt evaluation.
What monitoring is recommended for RTH-Beta’s liver and metabolic health?
Monitoring may include blood tests for cholesterol and liver enzymes. Liver fat can occur, and additional imaging such as FibroScan is usually considered when personal risk factors or abnormal findings make it appropriate rather than as a routine test for everyone. Your clinician can choose the schedule based on your results.
What should be monitored in RTH-Alpha?
Monitoring for RTH-Alpha commonly focuses on height, growth, bone maturation, bowel function, heart rate, and anemia. Slow or fast heart rate may be especially relevant if levothyroxine (L-T4) is used. Children may need follow-up schedules tailored to their development.
Can I develop Hashimoto’s or Graves’ disease if I have RTH?
Yes. RTH does not prevent other thyroid conditions, including Hashimoto’s thyroiditis and Graves’ disease. If Hashimoto’s reduces your thyroid hormone production, levothyroxine may be needed, and your results should be interpreted in light of your usual RTH pattern.
What should I carry to help other doctors understand my RTH?
Keep a current summary of your RTH subtype and genetic result, usual laboratory pattern, medicines, and endocrinologist’s contact information. A medical alert card can explain that abnormal thyroid tests should not lead to treatment changes without specialist input, while still allowing emergency care for a new medical problem. Sharing this information can help clinicians coordinate safely.

Get notified when new evidence is published on thyroid hormone resistance syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Cardiovascular Risk and Plasma N-terminal Pro-B-type Natriuretic Peptide in Adults With Resistance to Thyroid Hormone β.

    Davis TME, Davis WA, Moran C, et al.

    Journal of the Endocrine Society 2025; (9(4)):bvaf023 doi:10.1210/jendso/bvaf023.

    PMID: 40065989
  2. 2

    Resistance to Thyroid Hormone Beta and Coexisting Thyroid Disease: Diagnostic and Therapeutic Challenges Illustrated by Two Cases.

    Ribeiro S, Varela A, Queirós J

    Case reports in endocrinology 2025; (2025()):9523606 doi:10.1155/crie/9523606.

    PMID: 41163645
  3. 3

    Hypercholesterolemia in Two Siblings with Resistance to Thyroid Hormones Due to Disease-Causing Variant in Thyroid Hormone Receptor (THRB) Gene.

    Pajek M, Avbelj Stefanija M, Trebusak Podkrajsek K, et al.

    Medicina (Kaunas, Lithuania) 2020; (56(12)) doi:10.3390/medicina56120699.

    PMID: 33333891
  4. 4

    Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone β (RTHβ): a linked-record cohort study.

    Okosieme OE, Usman D, Taylor PN, et al.

    The lancet. Diabetes & endocrinology 2023; (11(9)):657-666 doi:10.1016/S2213-8587(23)00155-9.

    PMID: 37475119
  5. 5

    Clinical and laboratory characteristics of pediatric patients diagnosed with thyroid hormone resistance: A single-center experience.

    Kolbaşı B, Unal E, Durak H, et al.

    Endocrine 2026; (91(1)).

    PMID: 42319533
  6. 6

    Multigenerational thyroid hormone resistance due to THRβ mutation.

    Kopanos S, Feldkamp J

    European heart journal. Case reports 2025; (9(8)):ytaf338 doi:10.1093/ehjcr/ytaf338.

    PMID: 40761432
  7. 7

    Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β.

    Moran C, McEniery CM, Schoenmakers N, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(5)):e2005-e2014 doi:10.1210/clinem/dgab002.

    PMID: 33524107
  8. 8

    Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic-Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome.

    Domingues-Hajj PMS, Gomes PM, Magalhães PKR, Maciel LMZ

    Thyroid : official journal of the American Thyroid Association 2024; (34(8)):1038-1046 doi:10.1089/thy.2024.0132.

    PMID: 38877800
  9. 9

    Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta.

    Chaves C, Bruinstroop E, Refetoff S, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(7)):1127-1134 doi:10.1089/thy.2020.0651.

    PMID: 33353459
  10. 10

    Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone.

    Okazaki-Hada M, Nishihara E, Hisakado M, et al.

    European journal of endocrinology 2021; (186(1)):73-82.

    PMID: 34727089
  11. 11

    Coexistence of Autoimmune Hyper- and Hypothyroidism in a Kindred with Reduced Sensitivity to Thyroid Hormone.

    Abdellaoui Y, Magkou D, Bakopoulou S, et al.

    European thyroid journal 2020; (9(5)):263-268 doi:10.1159/000506424.

    PMID: 33088795
  12. 12

    Graves' Masquerade: A Case of Resistance to Thyroid Hormone (RTH) Syndrome.

    Chin YH, Anthony Bernard DM, Foo SH

    Cureus 2025; (17(1)):e78160 doi:10.7759/cureus.78160.

    PMID: 40027009
  13. 13

    A case of resistance to thyroid hormone beta and literature review: Case report.

    Yang Z, Ma S, Dong Y, et al.

    Medicine 2026; (105(18)):e48504 doi:10.1097/MD.0000000000048504.

    PMID: 42065173

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and other clinicians should tailor RTH monitoring, treatment, and follow-up to your symptoms, subtype, age, and pregnancy status.